Waters Stock Forecast, Price & News

11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Waters in the last twelve months. There are currently 3 sell ratings, 7 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Waters stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in WAT, but not buy additional shares or sell existing shares.
View analyst ratings for Waters or view top-rated stocks.

Wall Street analysts have given Waters a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Waters wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Waters is scheduled to release its next quarterly earnings announcement on Tuesday, July 27th 2021.
View our earnings forecast for Waters.

Waters Co. (NYSE:WAT) announced its quarterly earnings results on Wednesday, May, 5th. The medical instruments supplier reported $2.29 EPS for the quarter, topping analysts' consensus estimates of $1.57 by $0.72. The medical instruments supplier earned $608.55 million during the quarter, compared to analyst estimates of $522.81 million. Waters had a trailing twelve-month return on equity of 1,107.70% and a net margin of 24.56%. The company's revenue was up 30.9% on a year-over-year basis. During the same period last year, the business earned $1.15 earnings per share.
View Waters' earnings history.

Waters' stock was trading at $184.10 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, WAT shares have increased by 86.2% and is now trading at $342.71.
View which stocks have been most impacted by COVID-19.

Waters issued an update on its second quarter 2021 earnings guidance on Wednesday, May, 26th. The company provided EPS guidance of 2.150-2.250 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.110. The company issued revenue guidance of $603.18 million-$623.98 million, compared to the consensus revenue estimate of $596.35 million.

11 equities research analysts have issued 12-month price objectives for Waters' shares. Their forecasts range from $185.00 to $300.00. On average, they anticipate Waters' stock price to reach $251.25 in the next twelve months. This suggests that the stock has a possible downside of 26.7%.
View analysts' price targets for Waters or view top-rated stocks among Wall Street analysts.

13 employees have rated Waters CEO Udit Batra on Glassdoor.com. Udit Batra has an approval rating of 100% among Waters' employees. This puts Udit Batra in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to Waters include Thermo Fisher Scientific (TMO), Illumina (ILMN), Agilent Technologies (A), Mettler-Toledo International (MTD), Bio-Rad Laboratories (BIO), Charles River Laboratories International (CRL), PerkinElmer (PKI), Bio-Techne (TECH), Bruker (BRKR), Pacific Biosciences of California (PACB), Luminex (LMNX), Fluidigm (FLDM), Harvard Bioscience (HBIO), aTyr Pharma (LIFE) and BG Medicine (BGMD).
View all of WAT's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Waters investors own include Thermo Fisher Scientific (TMO), Honeywell International (HON), Raytheon Technologies (RTX), CVS Health (CVS), The Home Depot (HD), Johnson & Johnson (JNJ), Abbott Laboratories (ABT), Verizon Communications (VZ), Cisco Systems (CSCO) and Walmart (WMT).

Waters trades on the New York Stock Exchange (NYSE) under the ticker symbol "WAT."

Waters' stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (7.99%), Bank of New York Mellon Corp (7.46%), Massachusetts Financial Services Co. MA (5.67%), Janus Henderson Group PLC (1.96%), Geode Capital Management LLC (1.67%) and Champlain Investment Partners LLC (1.60%). Company insiders that own Waters stock include Christopher J Oconnell, Edward Conard, Elizabeth B Rae, Francis Kim, Ian King, Joann A Reed, Keeley A Aleman, Laurie H MD Glimcher, Linda Baddour, Mark T Beaudouin, Michael C Harrington, Michael J Berendt, Robert G Carson and Sherry Buck.
View institutional ownership trends for Waters.

WAT stock was sold by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, Janus Henderson Group PLC, Lord Abbett & CO. LLC, Mondrian Investment Partners LTD, UBS Asset Management Americas Inc., O Shaughnessy Asset Management LLC, D. E. Shaw & Co. Inc., and Morgan Stanley. Company insiders that have sold Waters company stock in the last year include Christopher J Oconnell, Edward Conard, Ian King, Joann A Reed, Linda Baddour, Michael C Harrington, Michael J Berendt, Robert G Carson, and Sherry Buck.
View insider buying and selling activity for Waters or view top insider-selling stocks.

WAT stock was purchased by a variety of institutional investors in the last quarter, including Point72 Asset Management L.P., BlackRock Inc., Eaton Vance Management, Renaissance Technologies LLC, Woodline Partners LP, Arrowstreet Capital Limited Partnership, Panagora Asset Management Inc., and Champlain Investment Partners LLC.
View insider buying and selling activity for Waters or or view top insider-buying stocks.

Shares of WAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of WAT stock can currently be purchased for approximately $342.71.

Waters has a market capitalization of $21.15 billion and generates $2.37 billion in revenue each year. The medical instruments supplier earns $521.57 million in net income (profit) each year or $9.05 on an earnings per share basis.

Waters employs 7,400 workers across the globe.

The following companies are subsidiares of Waters: Analytical Products Group Inc., Andrew Alliance, Andrew Alliance S.A, Andrew Alliance SA (Switzerland), Andrew Alliance SASU (France), Anter Corporation, Baehr Thermoanalyse GmbH, Blue Reference Inc., Calorimetry Sciences Corporation, ElectroForce, Environmental Resource Associates Inc. (Colorado), Environmental Resources Associates, Integrated Software Solutions Limited (UK), Integrated Software Solutions Pty Limited, Integrated Software Solutions USA LLC, MPE Orbur Group Ltd. (UK), Manchester International Limited (Cayman), Melbourne International Limited (Cayman), Micromass Holdings Ltd. (UK), Micromass Ltd. (UK), Micromass UK Ltd. (UK), Midland Precision Equipment Co. Ltd. (UK), Milford International Limited (Cayman), Nihon Waters K.K. (Japan), NuGenesis Technologies Corporation, Rubotherm, TA Instruments Japan Inc. (Japan), TA Instruments-Waters LLC (Delaware), Thar Instruments Inc, Thermometric AB, VICAM, VTI Corporation, Waters (TC) Israel Ltd. (Israel), Waters A/S (Denmark), Waters AG (Switzerland), Waters Analytical Instruments Sdn Bhd (Malaysia), Waters Asia Limited (Delaware), Waters Australia PTY LTD. (Australia), Waters Celtic Holdings Ltd. (Ireland), Waters China Ltd. (Hong Kong), Waters Chromatography BV (Netherlands), Waters Chromatography Europe BV (Netherlands), Waters Chromatography Ireland Ltd. (Ireland), Waters Corporation (Delaware), Waters Cromatografia SA (Spain), Waters European Investments LLC (Cayman) (2), Waters Ges.MBH (Austria), Waters Global International Limited (Cayman) (1), Waters Global Limited (UK) (1), Waters GmbH (Germany), Waters Holdings LLC (Delaware), Waters India Pvt. Ltd., Waters Kft (Hungary), Waters Korea Limited (Korea), Waters Limited (Canada), Waters Limited (UK), Waters Luxembourg SARL (Luxembourg), Waters NV (Belgium), Waters O.O.O. (Russia) (1), Waters Pacific Pte Ltd. (Singapore), Waters Research Center Kft (Hungary), Waters Romania Srl, Waters SA de CV (Mexico), Waters SAS (France), Waters Sp.Zo.o (Poland), Waters SpA (Italy), Waters Sverige AB (Sweden), Waters Tech. LC-MS Unipessol Lda (Portugal), Waters Technologies (Beijing) Co. Ltd (China), Waters Technologies (Shanghai) Ltd (China), Waters Technologies Corporation (Delaware), Waters Technologies International Limited (Cayman) (1), Waters Technologies Ireland Ltd. (Ireland), and Waters Technologies do Brasil Ltda (Brazil).

Waters was founded in 1958.

The official website for Waters is www.waters.com.

Waters is headquartered at 34 MAPLE STREET, MILFORD MA, 01757.

Waters' mailing address is 34 MAPLE STREET, MILFORD MA, 01757. The medical instruments supplier can be reached via phone at 508-478-2000 or via email at [email protected]